This test is most useful if any of these apply to you.
Plasma glucose shows how much sugar is circulating when your blood is drawn. It can be measured after fasting, without fasting, or during an oral glucose tolerance test. Those results answer different questions, so the timing matters.
A fasting sample is an established way to detect prediabetes and diabetes before symptoms appear. But insulin resistance can develop while fasting glucose stays steady, and some problems appear only after meals or a glucose drink. One fasting result gives an incomplete picture of your glucose regulation.
Your cells use glucose for energy. After a meal, much of it comes from food. Between meals, your liver releases stored glucose and makes more to maintain the supply. Insulin from your pancreas helps muscle and fat take up glucose and restrains glucose production by the liver.
Type 2 diabetes usually develops when tissues respond less to insulin and the pancreas can no longer produce enough insulin to compensate. Reduced responsiveness is called insulin resistance. Excess glucose production by the liver contributes to rising fasting glucose, but the result also depends on insulin production and other processes. It cannot identify which part of the system is failing.
This test measures glucose in plasma from a blood draw. Plasma is the liquid portion of blood separated from its cells before clotting. The result is reported in mg/dL.
Fasting plasma glucose, HbA1c, and glucose measured during an oral glucose tolerance test are established tools for diagnosing diabetes. HbA1c estimates average glucose exposure over roughly the previous two to three months. An oral glucose tolerance test measures your response to a standardized glucose drink.
These tests identify overlapping groups of people. In a network meta-analysis using the two-hour glucose tolerance result as the comparison, fasting plasma glucose and HbA1c each missed some cases. Counting either fasting glucose or HbA1c as positive identified more cases than either test alone. That finding doesn't mean a normal fasting result rules out diabetes.
| Who Was Studied | What Was Compared | What They Found |
|---|---|---|
| Adults in screening studies from seven African countries | HbA1c against an oral glucose tolerance test | HbA1c at the usual diagnostic criterion missed a substantial share of the cases identified by the glucose tolerance test. |
| Adults in pooled studies of prediabetes screening | Fasting glucose and HbA1c against glucose tolerance testing | Fasting glucose missed many people with impaired glucose tolerance. These tests capture different forms of abnormal glucose regulation. |
| 1,797 glucose tolerance test records from a Brazilian laboratory | One-hour glucose against conventional measures | The one-hour result identified additional glucose abnormalities. The study was cross-sectional, so it did not establish whether those additional findings predicted future disease. |
The one-hour result has enough supporting evidence that the International Diabetes Federation recommends its use in people at risk. The American Diabetes Association's standard diagnostic options still use fasting glucose, HbA1c, the two-hour glucose tolerance result, and a random glucose measurement in someone with classic symptoms. The one-hour measurement can add information, but interpretation should follow a defined testing protocol.
Wearable sensors measure glucose in fluid under the skin. Research has found glucose excursions in people whose standard laboratory results were normal, but the health meaning of every excursion is unsettled. Continuous monitoring has not been established as a substitute for laboratory testing to diagnose prediabetes or diabetes.
Diabetes increases the risk of heart disease and stroke and can damage the eyes, kidneys, and nerves. Long-term glucose exposure contributes to these complications, but a single fasting value cannot measure that exposure or summarize your cardiovascular risk. Blood pressure, cholesterol, smoking, kidney function, and how long you've had diabetes also matter.
Risk develops across a continuum. Observational studies have found that higher fasting plasma glucose predicts future type 2 diabetes even among people who do not meet diagnostic criteria. That association does not establish one lowest-risk target for everyone or prove that lowering an already healthy result with medication improves outcomes.
Low glucose can impair brain function and cause sweating, shakiness, confusion, seizures, or loss of consciousness. In diabetes, the risk is especially relevant with insulin and medicines that stimulate insulin release. Missed meals, exercise, kidney disease, and other changes can make a previously appropriate treatment plan cause lows.
Severe hypoglycemia is associated with cardiovascular events and death. It can also mark underlying illness or vulnerability, so these associations do not prove that low glucose alone caused every event. A lower result is not automatically a healthier result.
Maternal glucose crosses the placenta, and high glucose during pregnancy is associated with complications for both mother and baby. In a follow-up study of 4,160 mother-child pairs, children whose mothers had untreated gestational diabetes were more likely to have impaired glucose tolerance at ages 10 to 14. The mothers' classification used fasting and post-drink plasma glucose together, so this finding cannot be attributed to a fasting result alone.
The study supports an association with later childhood glucose regulation. It does not show that one maternal result determines a child's future health or that treatment necessarily prevents every long-term outcome.
Illness and surgery can raise glucose through stress hormones, changes in insulin action, and treatment effects. A high result during illness may reflect a temporary response, previously unrecognized diabetes, or both. HbA1c can help assess whether glucose was already running high before the illness, provided nothing is distorting the HbA1c result.
Blood cells keep consuming glucose after collection. Unless the laboratory promptly separates the plasma or uses an effective preservation protocol, the result can be falsely low. Sodium fluoride alone does not stop this process immediately. In a study involving more than 12,000 pregnant women, earlier sample processing increased glucose concentrations and the proportion diagnosed with gestational diabetes.
Fasting glucose varies from day to day. In the Hoorn Study, which included 524 adults tested twice, most of the variation came from normal biological differences between testing days rather than laboratory measurement error.
A persistent upward pattern can add context to your risk, but small changes across a few readings do not necessarily represent disease progression. Comparisons are more useful when the collection conditions are similar. For established diabetes, HbA1c and home or continuous glucose monitoring usually provide more information about treatment response than occasional fasting laboratory measurements alone.
Evidence-backed interventions that affect your Glucose level
Glucose is best interpreted alongside these tests.
Glucose is included in these pre-built panels.
See how your body handles sugar in real time, and catch rising diabetes risk years before a fasting test ever notices.
3 biomarkersGlucose checked every 30 minutes for a detailed curve that catches spikes an hourly test can miss.
5 biomarkersMost comprehensive OGTT panel with 7 timepoints, providing an in-depth analysis of glucose metabolism over 3 hours.
7 biomarkersGlucose and insulin checked every hour, so you see not just your blood sugar but how hard your body works to control it.
6 biomarkersGlucose and insulin every 30 minutes, the most complete view of your blood sugar and insulin response.
10 biomarkersSee how hard your body is working to keep your blood sugar normal, often long before a routine test would flag a problem.
14 biomarkers